Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy.
Franzese C, Cozzi L, Badalamenti M, Baldaccini D, D'Agostino G, Fogliata A, Navarria P, Franceschini D, Comito T, Clerici E, Reggiori G, Tomatis S, Scorsetti M.
Franzese C, et al. Among authors: fogliata a.
Strahlenther Onkol. 2022 Aug;198(8):710-718. doi: 10.1007/s00066-021-01886-y. Epub 2022 Jan 21.
Strahlenther Onkol. 2022.
PMID: 35059760